Literature DB >> 22000646

Urate transporters: an evolving field.

Naohiko Anzai1, Hitoshi Endou.   

Abstract

Urate (uric acid) is the end product of purine metabolism in human beings owing to the genetic loss of hepatic urate oxidase (uricase). Despite its potential advantage as an antioxidant, sustained hyperuricemia is associated with gout, renal diseases, hypertension, and cardiovascular diseases. Because the kidney plays a dominant role in maintaining serum urate levels through its excretion, it is important to understand the molecular mechanism of renal urate handling. Although molecular identification of the urate/anion exchanger URAT1 (SLC22A12) in 2002 paved the way for successive identification of several urate transport-related proteins, the entire picture of effective renal urate handling in human beings has not yet been clarified. Recently, several genome-wide association studies have revealed close associations between serum urate levels and single nucleotide polymorphisms in at least 10 genetic loci including eight transporter-related genes. These findings led us to consider the roles of urate transporters in extrarenal tissues such as the intestine. In this review, we discuss various aspects of transmembrane transport of urate in the human body.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22000646     DOI: 10.1016/j.semnephrol.2011.08.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  11 in total

Review 1.  Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Authors:  Ambreen Gul; Philip Zager
Journal:  Curr Diab Rep       Date:  2018-03-01       Impact factor: 4.810

Review 2.  SLC transporters as therapeutic targets: emerging opportunities.

Authors:  Lawrence Lin; Sook Wah Yee; Richard B Kim; Kathleen M Giacomini
Journal:  Nat Rev Drug Discov       Date:  2015-06-26       Impact factor: 84.694

3.  Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function.

Authors:  Kim Hughes; Tanya Flynn; Janak de Zoysa; Nicola Dalbeth; Tony R Merriman
Journal:  Kidney Int       Date:  2013-09-18       Impact factor: 10.612

4.  Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9.

Authors:  Brian J DeBosch; Oliver Kluth; Hideji Fujiwara; Annette Schürmann; Kelle Moley
Journal:  Nat Commun       Date:  2014-08-07       Impact factor: 14.919

Review 5.  Renal transport of uric acid: evolving concepts and uncertainties.

Authors:  Ion Alexandru Bobulescu; Orson W Moe
Journal:  Adv Chronic Kidney Dis       Date:  2012-11       Impact factor: 3.620

Review 6.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

7.  Spironolactone increases serum uric acid levels in patients with chronic kidney disease.

Authors:  S E Cabrera; N C Edwards; R P Steeds; J N Townend; C J Ferro
Journal:  J Hum Hypertens       Date:  2013-07-18       Impact factor: 3.012

8.  Variation of urate transport in the nephrons in subtypes of hyperuricemia.

Authors:  Toru Nakamura; Rie Nishi; Tuneo Tanaka; Kazutaka Takagi; Katsuya Sakai; Mihoko Takai; Shigeru Morishima; Takahiro Yamauchi; Takanori Ueda
Journal:  Nephron Extra       Date:  2013-08-20

9.  Noncoding origins of anthropoid traits and a new null model of transposon functionalization.

Authors:  Ricardo C H del Rosario; Nirmala Arul Rayan; Shyam Prabhakar
Journal:  Genome Res       Date:  2014-07-20       Impact factor: 9.043

10.  Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares.

Authors:  Tanya J Flynn; Murray Cadzow; Nicola Dalbeth; Peter B Jones; Lisa K Stamp; Jennie Harré Hindmarsh; Alwyn S Todd; Robert J Walker; Ruth Topless; Tony R Merriman
Journal:  BMC Musculoskelet Disord       Date:  2015-08-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.